Glimixia-VM1 Tablet ER
Manufacturer
Wings Biotech Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Key Information
Short Description
Glimixia-VM1 Tablet ER is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Dosage Form
Tablet ER
Introduction
Glimixia-VM1 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimixia-VM1 Tablet ER is to be taken empty stomach.
How it works
Glimixia-VM1 Tablet ER is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal.
Related Medicines
Voglistar GM1 Tablet
Gemer V1 Tablet
Voglistar GM1 Tablet
Glymipril-MV 1 Tablet ER
Xmet-Trio 500/0.2/1 Tablet ER
Volix Trio 1 Tablet ER
Glimezan V 1 Tablet ER
Vognova GM 1 Tablet ER
Mepgud GV 1mg/500mg/0.2mg Tablet ER
Glimulin MV 1 Tablet ER
Frequently asked questions
What is Glimixia-VM1 Tablet ER?
Glimixia-VM1 Tablet ER is a combination medication for the treatment of type 2 diabetes mellitus (DM). It contains Glimepiride, Metformin and Voglibose. This medicine helps improve blood glucose levels in adults when taken with proper diet and exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production by the liver and improves insulin sensitivity, while Voglibose is an alpha-glucosidase inhibitor that targets postprandial (after meals) glucose levels.
What are the possible side effects of Glimixia-VM1 Tablet ER?
Common side effects associated with Glimixia-VM1 Tablet ER include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste perception, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Are there any specific conditions in which Glimixia-VM1 Tablet ER should not be taken?
Avoid using Glimixia-VM1 Tablet ER if you have known allergies to any of its components or excipients. Also, avoid this medication if you have moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcers, and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to drink alcohol while taking Glimixia-VM1 Tablet ER?
No, drinking alcohol while taking Glimixia-VM1 Tablet ER is not recommended. It can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Glimixia-VM1 Tablet ER cause hypoglycemia?
Yes, using Glimixia-VM1 Tablet ER may cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It's more likely to happen if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medications simultaneously.
What are the instructions for the storage and disposal of Glimixia-VM1 Tablet ER?
Store Glimixia-VM1 Tablet ER in its original container with a tight seal. Follow the instructions on the label. Dispose of unused medication properly. Ensure it is inaccessible to pets, children, and other individuals.
